CN102526381A - Traditional Chinese medicine preparation for treating schizophrenia - Google Patents
Traditional Chinese medicine preparation for treating schizophrenia Download PDFInfo
- Publication number
- CN102526381A CN102526381A CN2010106237351A CN201010623735A CN102526381A CN 102526381 A CN102526381 A CN 102526381A CN 2010106237351 A CN2010106237351 A CN 2010106237351A CN 201010623735 A CN201010623735 A CN 201010623735A CN 102526381 A CN102526381 A CN 102526381A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine preparation
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
The invention relates to a traditional Chinese medicine preparation for treating schizophrenia, and the traditional Chinese medicine preparation has the advantages of good curative effect and less side effect. The traditional Chinese medicine preparation is prepared from the following raw materials in parts by weight: 10-40 parts of lapis chloriti, 20-70 parts of Chinese eaglewood, 10-40 parts of rhubarb, 25-50 parts of sandalwood, 30-40 parts of scorpion, 5-8 parts of radix aucklandiae, 25-40 parts of radix bupleuri, 20-30 parts of cornu saigae tataricae, 10-20 parts of calculus bovis factitious, 30-50 parts of radix scutellariae, 20-30 parts of rhizoma acori tatarinowii, 20-30 parts of radix salviae miltiorrhizae, 30-50 parts of panax pseudoginseng and 30-40 parts of radix paeoniae rubra; and the raw materials are mixed, extracted and purified to obtain powder which is then packaged to obtain the traditional Chinese medicine preparation. The traditional Chinese medicine preparation for treating schizophrenia provided by the invention is a prescription developed based on years of clinical experiences of our hospital, and wins warm welcome of patients due to the obvious curative effect.
Description
(1) technical field
What the present invention relates to is a kind of medicine configuration article, a kind ofly specifically is used to treat schizoid Chinese medicine preparation.
(2) background technology
Schizophrenia is with basic personality change, the division of thinking, emotion, behavior, and the inharmonious of ergasia and environment is one type of modal psychosis of principal character.Good sending out in person between twenty and fifty was mainly between 16～40 years old, do not have organic change; Be a kind of functional psychosis, the obstacle of this patient general unconscious and intelligent aspect, but not only influence my work capacity when showing effect; And also influential to family and society, should cause people from all walks of life's concern.Some time can be suffered from schizophrenia to nearly 1% population in life at them.Estimate that the whole world has 4500 to 5,000 ten thousand people to suffer from schizophrenia, wherein 3,300 ten thousand in developing country.Schizophrenia is modal one group of psychosis in the psychosis, and the survey data in six districts of the U.S. shows that its annual morbidity is 0.43 ‰～0.69 ‰; More than 15 years old is 0.30 ‰～1.20 ‰ (Babigian, 1975), and China some areas are 0.09 ‰; According to international schizophrenia pilot investigation (IPSS) data; The investigation report of investigating people more than 3000 in more than 20 year is lasted at 20 centers of 18 countries, and the schizophrenia annual morbidity is between 0.2 ‰～0.6 ‰ among the general crowd; Average 0.3 ‰ (Shinfuku, 1992).
More the schizophrenia course of disease is delayed and is and carry out sexual development, should give rational therapy as early as possible like early discovery, and the most of patients prognosis is comparatively optimistic; Small number of patients has been delayed the time because treatment is untimely, unreasonable; Affect diagnoses and treatment adversely, the state of an illness is slowly made progress, even lost the treatment good opportunity; Mental deterioration occurs, become spiritual maimed person.Therefore should give diagnosis and treatment as early as possible, in the hope of good effect.
Schizophrenia is used following medicine always:
1. phenothiazines (chlorpromazine, perphenazine, trifluoperazine, fluphenazine);
2. dibenzoxazepines (clozapine);
3. atypical antipsychotic agents: as risperidone, Quetiapine, etc.
There are limbs strong in the therapeutic process, move side effect such as dumb, weight increase.
Though there are problems such as side effect is big, relapse rate is high, part patient's curative effect is not remarkable in western medical treatment schizophrenia determined curative effect.Adopt the treatment of combination of Chinese and Western medicine method to obtain bigger progress in recent years.Acute and chronic schizophrenia adopts Chinese medicine compound to cooperate low dose of psychosis western medicine, and curative effect is superior to simple Chinese medicine or western medicine, and can reduce dosage and untoward reaction.
(3) summary of the invention
The object of the invention is to provide a kind of therapeutic effect good, the schizoid Chinese medicine preparation of treatment that side effect is little.
The objective of the invention is to realize like this: it by weight portion is: Lapis Chloriti 10-40 part, Lignum Aquilariae Resinatum 20-70 part, Radix Et Rhizoma Rhei 10-40 part, Lignum Santali Albi 25-50 part, Scorpio 30-40 part, Radix Aucklandiae 5-8 part, Radix Bupleuri 25-40 part, Cornu Saigae Tataricae 20-30 part, artificial Calculus Bovis 10-20 part, Radix Scutellariae 30-50 part, Rhizoma Acori Graminei 20-30 part, Radix Salviae Miltiorrhizae 20-30 part, Radix Notoginseng 30-50 part, Radix Paeoniae Rubra 30-40 part are formed.
The present invention is my institute clinical experience prescription for many years, because the welcome that receives the patient deeply evident in efficacy.
Be monarch with Lapis Chloriti, Lignum Aquilariae Resinatum in the invention, the dry brave heavy bob of its property of Lapis Chloriti, kind can attacking weighed down the old expectorant that Chen Jifu hides; The male sedimentation of its property gas of Lignum Aquilariae Resinatum is for controlling the QI rising in reverse order, the stagnation of QI, depressed key medicine.The two compatibility, ability dispelling the stagnated QI eliminating phlegm can be attacked by persistent ailment especially greatly.Minister is cleansed excess-heat with Radix Et Rhizoma Rhei, opens the descending road of phlegm-fire; The Lignum Santali Albi the chest stuffiness relieving of regulating the flow of vital energy, the row chest and diaphragm is stopped up the gas that stagnates; Scorpio relieves dizziness, high fever, infantile convulsions, epilepsy, etc. and jerks surely, the convulsion of stopping up on the flat wind-phlegm.Assistant is with the Radix Aucklandiae, Radix Bupleuri depressed liver-energy dispersing and QI regulating, to transfer the strongly fragrant of irritability; Cornu Saigae Tataricae, artificial Calculus Bovis, Radix Scutellariae clearing heart fire are to help the power of removing heat-phlegm; The Rhizoma Acori Graminei waking up the patient from unconsciousness by dissipating phlegm is to play the merit of refreshment; Radix Salviae Miltiorrhizae, Radix Notoginseng, Radix Paeoniae Rubra blood circulation promoting and blood stasis dispelling are to separate the strongly fragrant of gods.The dispelling the stagnated QI clearing away phlegm is played, the effect of the refreshment of having one's ideas straightened out altogether by comprehensive full side.
The neural section hospital of Kang Yuan has carried out the clinical observation test in Heilungkiang to adopt the present invention, and result of the test is listed following table in.
Treatment schizophrenia 400 routine clinical effectivenesses
(4) specific embodiment
For example the present invention is made more detailed description below: be according to weight portion: the ratio of Lapis Chloriti 10-40 part, Lignum Aquilariae Resinatum 20-70 part, Radix Et Rhizoma Rhei 10-40 part, Lignum Santali Albi 25-50 part, Scorpio 30-40 part, Radix Aucklandiae 5-8 part, Radix Bupleuri 25-40 part, Cornu Saigae Tataricae 20-30 part, artificial Calculus Bovis 10-20 part, Radix Scutellariae 30-50 part, Rhizoma Acori Graminei 20-30 part, Radix Salviae Miltiorrhizae 20-30 part, Radix Notoginseng 30-50 part, Radix Paeoniae Rubra 30-40 part with each raw materials mix, extract, be purified to powder and dress up.
Claims (1)
- One kind the treatment schizoid Chinese medicine preparation, it is characterized in that: be according to weight portion: the ratio of Lapis Chloriti 10-40 part, Lignum Aquilariae Resinatum 20-70 part, Radix Et Rhizoma Rhei 10-40 part, Lignum Santali Albi 25-50 part, Scorpio 30-40 part, Radix Aucklandiae 5-8 part, Radix Bupleuri 25-40 part, Cornu Saigae Tataricae 20-30 part, artificial Calculus Bovis 10-20 part, Radix Scutellariae 30-50 part, Rhizoma Acori Graminei 20-30 part, Radix Salviae Miltiorrhizae 20-30 part, Radix Notoginseng 30-50 part, Radix Paeoniae Rubra 30-40 part with each raw materials mix, extract, be purified to powder constituent.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010106237351A CN102526381A (en) | 2010-12-27 | 2010-12-27 | Traditional Chinese medicine preparation for treating schizophrenia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010106237351A CN102526381A (en) | 2010-12-27 | 2010-12-27 | Traditional Chinese medicine preparation for treating schizophrenia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102526381A true CN102526381A (en) | 2012-07-04 |
Family
ID=46335201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010106237351A Pending CN102526381A (en) | 2010-12-27 | 2010-12-27 | Traditional Chinese medicine preparation for treating schizophrenia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102526381A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1334121A (en) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
| CN1513519A (en) * | 2003-06-04 | 2004-07-21 | 郑淑英 | Heart quieting and orifice opening capsule and its preparation |
| WO2007106049A1 (en) * | 2006-03-16 | 2007-09-20 | Moleac Pte Ltd | Combination therapy for treatment of patients with neurological disorders and cerebral infarction |
| CN101396494A (en) * | 2008-10-25 | 2009-04-01 | 宁甲保 | Traditional Chinese medicine preparation for treating schizophrenia and preparation method and restorative medicine thereof |
-
2010
- 2010-12-27 CN CN2010106237351A patent/CN102526381A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1334121A (en) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
| CN1513519A (en) * | 2003-06-04 | 2004-07-21 | 郑淑英 | Heart quieting and orifice opening capsule and its preparation |
| WO2007106049A1 (en) * | 2006-03-16 | 2007-09-20 | Moleac Pte Ltd | Combination therapy for treatment of patients with neurological disorders and cerebral infarction |
| CN101396494A (en) * | 2008-10-25 | 2009-04-01 | 宁甲保 | Traditional Chinese medicine preparation for treating schizophrenia and preparation method and restorative medicine thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102631532A (en) | Method for preparing traditional Chinese medicine (TCM) for treating heat toxicity type acute lymphangitis | |
| CN101057940A (en) | Apoplexy recover pills | |
| CN102652805A (en) | Medicine for treating rabies | |
| CN1994411A (en) | Medicine for treating cerebral apoplexy | |
| CN104127567B (en) | A kind of Chinese medicine composition for the treatment of diabetic peripheral neuropathy | |
| CN102836338B (en) | Chinese medicament for treating cardia-cerebrovascular diseases | |
| CN102114195A (en) | Anti-drug capsule prepared from pure traditional Chinese medicines | |
| CN104189363A (en) | Traditional Chinese medicinal herb for preventing and radically treating nephropathy | |
| CN103301411A (en) | Traditional Chinese medicine wine for treating soft tissue injury and preparation method thereof | |
| CN103479737A (en) | Traditional Chinese medicine composition for treating senile cutaneous pruritus and application thereof | |
| CN102670919A (en) | Chinese medicament for treating chronic pyelonephritis | |
| CN101757329B (en) | Traditional Chinese medicine thrombolysis capsule for treating cerebral thrombosis | |
| CN103385998B (en) | Traditional Chinese medicine preparation used for treating infantile dysentery | |
| CN102988559B (en) | Chinese medicinal enema for treating ulcerative colitis | |
| CN102526381A (en) | Traditional Chinese medicine preparation for treating schizophrenia | |
| CN104225387A (en) | Traditional Chinese medicine composition for treating damp-heat blocked type diabetes feet | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN103239577A (en) | Traditional Chinese medicinal preparation for treating schizophrenia | |
| CN105213501A (en) | Treat schizoid Chinese medicine preparation | |
| CN102274330B (en) | Medicament for treating beriberi | |
| CN1181835C (en) | Chinese medicine preparation for treating rheumatism and rheumatoid disease | |
| CN102370916A (en) | Traditional Chinese medicine for treating acute glomerulonephritis | |
| CN102631633B (en) | Preparation method for traditional Chinese medicine wash lotion for treating constipation type acute lymphangitis | |
| CN103006998B (en) | Medicine for treating acute glomerulonephritis (AGN) hypertensive crisis | |
| CN101190300B (en) | Medicine for curing cerebral infarction and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120704 |